Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)

NCT00916630

Conditions: Central Nervous System Lymphoma, Disease Attributes, Pathologic Processes, +2 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Optic Neuritis Recovery After Oral or IV Corticosteroids

NCT01524250

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +12 more
Locations: London Health Sciences Center London, Ontario, Canada

London Health Sciences Center London, Ontario, Canada

View Trial Details

Completed

Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

NCT00086125

Conditions: Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +19 more
Locations: University of Chicago Hospitals, Section of Hematology/Oncology Chicago, Illinois, United States

Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place St Louis, Missouri, United States

The Cancer Institute of New Jersey New Brunswick, New Jersey, United States

New York Presbyterian Hospital, Weill College of Cornell University New York, United States

View Trial Details

Completed

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia

NCT02520895

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
Locations: Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Completed

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT01014208

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Chicago, Illinois, United States

GSK Investigational Site Chicago, Illinois, United States

View all 173 locations

View Trial Details

Completed

Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma

NCT00547534

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Nebraska Medical Center Omaha, Nebraska, United States

Cornell Wiell Medical College New York, United States

University of Rochester Medical Center (James P. Wilmot Cancer Center) Rochester, New York, United States

View Trial Details

Completed

A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

NCT00886132

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +18 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

NCT00003414

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer

NCT00706316

Conditions: DNA Virus Infections, Disease Attributes, Epstein-Barr Virus Infections, +20 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Recurrence

Recurrence trial results

Related conditions